Targeting integrins in hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

Targeting integrins in hepatocellular carcinoma.

Targeting integrins in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q37844564

about

Resveratrol down-regulates Myosin light chain kinase, induces apoptosis and inhibits diethylnitrosamine-induced liver tumorigenesis in rats.Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems.A novel three-dimensional culture system maintaining the physiological extracellular matrix of fibrotic model livers accelerates progression of hepatocellular carcinoma cells.The cross-talk of LDL-cholesterol with cell motility: insights from the Niemann Pick Type C1 mutation and altered integrin trafficking.Endothelial transdifferentiation in hepatocellular carcinoma: loss of Stabilin-2 expression in peri-tumourous liver correlates with increased survival.Basolateral CD147 Induces Hepatocyte Polarity Loss by E-cadherin Ubiquitination and Degradation in Hepatocellular Carcinoma Progress.Conjugated polymer amplified far-red/near-infrared fluorescence from nanoparticles with aggregation-induced emission characteristics for targeted in vivo imaging.Molecular Targets in Hepatocarcinogenesis and Implications for Therapy

P2860

Q36590160-FE7CABD8-8721-46EB-8D4A-4E011AB4A771 Q38271422-8C33D0A0-E3A8-4418-BF04-9EBFD614344D Q41550215-4BDB9CB5-A766-43FB-BE96-4B0C861A82C6 Q41780762-14291032-5CD7-4C40-8455-E92680207A84 Q47976287-D5F4F047-A345-4410-AD56-F299B1CB0EE4 Q49884171-0D2CC803-5B49-4924-A95E-79AE4FFBD1AA Q50499834-22FF25DC-A6A2-418A-8817-948B84FA4084 Q58784853-19AC5B63-79A5-4A1F-9FF2-ACC60421CF15

P2860

Targeting integrins in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q37844564

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 February 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeting integrins in hepatocellular carcinoma.

@en

Targeting integrins in hepatocellular carcinoma.

@nl

type

label

Targeting integrins in hepatocellular carcinoma.

@en

Targeting integrins in hepatocellular carcinoma.

@nl

prefLabel

Targeting integrins in hepatocellular carcinoma.

@en

Targeting integrins in hepatocellular carcinoma.

@nl

P1433

Q37844564-AFBA9432-B1C3-4D23-B7BE-3FB09E0FB8B0

P1476

Q37844564-1AF0A27E-9A7D-4565-8EBD-17AA29B783C5

P2093

Q37844564-010637D0-CA2D-45E0-A768-7232C3CEA5D4

Q37844564-2B416670-F1D1-45C7-B564-96B86BA92C37

Q37844564-3B851C6F-F58B-44D0-A13D-72783183919E

Q37844564-A4363F0E-19CA-451E-A199-37ABA39E1218

P2860

Q37844564-0271808F-E494-4BB8-995A-DEEF2AB307CE

Q37844564-038765E9-8B59-4E97-B36D-88CD54346F8B

Q37844564-050C22C3-6E12-4FD9-BD1B-5BE1CD261ADF

Q37844564-06CCE0A7-BF1B-4EC2-8FA9-2F94BAEB611F

Q37844564-08A56E7F-C0FC-4961-BE14-C4CCB8B6DAFF

Q37844564-0AD3BCCA-B632-4FFC-A91B-C6B8CC426866

Q37844564-0E11C373-6375-4DBE-8085-80F20628B09D

Q37844564-10DC243F-367D-4578-A2B4-724CBE8EC02F

Q37844564-118E2445-2CA8-4D2F-ABCE-CE0B92690288

Q37844564-165A79C8-B780-464B-980C-81DF1F700164

P304

Q37844564-E0C64071-0FFF-46D4-8A85-D32BA8C3FD1E

P31

Q37844564-757578CA-8C58-4747-80D8-F9EF312ABE4D

P356

Q37844564-390B5EF3-2773-4D18-BCB6-0B0DD5EC5BAE

P407

Q37844564-E34E2454-8B4E-49EC-9EED-2E027D255CC4

P433

Q37844564-7803E084-6634-4051-9119-A8E6954472BD

P478

Q37844564-59B18F3B-7EB3-4D40-AA9C-DE1D84501E36

P577

Q37844564-2E9B4451-5666-48C5-9F00-8682DDB843BF

P5875

Q37844564-AA515210-826F-4114-AFB9-F5B106F9B84D

P698

Q37844564-93F0CE23-FDD9-42FD-B7D8-667CB8C3F865

P356

14728222.2011.555402

P1433

Expert Opinion on Therapeutic Targets

P1476

Targeting integrins in hepatocellular carcinoma.

@en

P2093

Long Yu

http://www.w3.org/2001/XMLSchema#string

Shouyi Qiao

http://www.w3.org/2001/XMLSchema#string

Xiaojing Qiao

http://www.w3.org/2001/XMLSchema#string

Yanhua Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.

Distinct antitumor properties of a type IV collagen domain derived from basement membrane

Crystal structure of the extracellular segment of integrin alpha Vbeta3

Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand

Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins

Sequence and tissue distribution of the integrin alpha 9 subunit, a novel partner of beta 1 that is widely distributed in epithelia and muscle

Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer

Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis

P304

421-437

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.2011.555402

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49846673

http://www.w3.org/2001/XMLSchema#string

P698

21332366

http://www.w3.org/2001/XMLSchema#string